Chapter 18 Matrix Metalloproteinases, T Cell Homing and β‐Cell Mass in Type 1 Diabetes

This publication has 110 references indexed in Scilit:

• Conformational analyses of thiirane-based gelatinase inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2007
• Specific Inhibition of Autoimmune T Cell Transmigration Contributes to β Cell Functionality and Insulin Synthesis in Non-obese Diabetic (NOD) Mice
  Published by Elsevier ,2007
• MMP-2 functions as a negative regulator of chondrogenic cell condensation via down-regulation of the FAK-integrin β1 interaction
  Developmental Biology, 2007
• MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells
  British Journal of Cancer, 2007
• Mechanistic insights into targeting T cell membrane proteinase to promote islet β‐cell rejuvenation in type 1 diabetes
  The FASEB Journal, 2006
• Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism‐based selective gelatinase inhibitor
  International Journal of Cancer, 2006
• Mislocalization and unconventional functions of cellular MMPs in cancer
  Cancer and Metastasis Reviews, 2006
• Mint-3 Regulates the Retrieval of the Internalized Membrane-type Matrix Metalloproteinase, MT5-MMP, to the Plasma Membrane by Binding to Its Carboxyl End Motif EWV
  Journal of Biological Chemistry, 2004
• Treatment of epigallocatechin‐3‐gallate inhibits matrix metalloproteinases‐2 and ‐9 via inhibition of activation of mitogen‐activated protein kinases, c‐jun and NF‐κB in human prostate carcinoma DU‐145 cells
  The Prostate, 2003
• New functions for the matrix metalloproteinases in cancer progression
  Nature Reviews Cancer, 2002